Cabazitaxel

Back to search

Molecule Structure

Scientific Name

Cabazitaxel

Description of the Drug

Cabazitaxel is an antineoplastic agent used for the treatment of hormone-refractory metastatic prostate cancer previously treated with a docetaxel-containing treatment regimen.

Source: DrugBank Online – DrugBank.com. Retrieved 2023-02-07 from
http://www.drugbank.ca/drugs/DB06772

Brand Name(s)

Jevtana, Jevtana kit

Company Owner(s)

Sanofi Aventis Us Inc

Mechanism(s) Of Action

Target Name Target Type Action Type Target ChEMBL ID
Tubulin PROTEIN COMPLEX GROUP INHIBITOR CHEMBL2095182

Unichem Links

SureChEMBL SCHEMBL179674
PharmGKB PA165958401
Human Metabolome Database HMDB0015672
DrugBank DB06772
PubChem: Thomson Pharma 14816121 16397389
PubChem 9854073
Nikkaji J2.871.889F
EPA CompTox Dashboard DTXSID40171389
DrugCentral 4153
ChemicalBook CB42517227
Guide to Pharmacology 6798
GSRS 3755f36d-ea5d-40e0-a2c0-49d8c4280c3a
rxnorm JEVTANA CABAZITAXEL
ChEBI 63584
ZINC ZINC000085536932